Spin-out Silicon Microgravity secures $7m investment, appoints CEO
Silicon Microgravity (SMG), a spin-out from both BP and the University of Cambridge, has raised $7 million from IP Group, Parkwalk, BP Ventures and Cambridge Enterprise.
Microbiotica signs major collaboration with Genentech
Microbiotica, a Cambridge Innovation Capital portfolio company, has entered into a multi-year strategic collaboration with Genentech worth up to $534 million. The companies will work together to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease (IBD).
University of Cambridge spin-out Sorex Sensors raises £1.2m
Cambridge Enterprise, the Cambridge Angels and Cambridge Capital Group have completed an initial round of investment in Sorex Sensors Limited, a spin-out company from the Department of Engineering at the University of Cambridge.
Cambridge and Shandong University sign agreement to support innovation and entrepreneurship
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, has signed an agreement with one of China’s largest universities to encourage innovation and entrepreneurship in one of China’s fastest-growing high-tech clusters.
Cambridge University spin-outs top list for capital raised, 2013-17; rank 2nd in total deals
An annual data review published by Global University Venturing reports that University of Cambridge spin-outs raised $2,216m in capital for 2013-17, putting it at the top of the global list of universities. The article also reports that in this period Cambridge’s spin-outs closed 96 deals, making it second only to Stanford University in total number of deals, though ahead of it in total capital…
Paragraf closes £2.9m seed round to drive production of graphene based technologies
Paragraf, the graphene technology development company, a recent spin out from the University of Cambridge, has closed a £2.9 million seed round to support the development of its first major products. The round is led by Cambridge Enterprise, the commercialisation arm of the University of Cambridge, with the participation of Parkwalk Advisors, Amadeus Capital Partners, IQ Capital Partners and…
Aurelius and University win Horizon 2020 grant to revolutionise lead-acid battery recycling
Aurelius Environmental, part of Aurelius Holdings, and Dr Vasant Kumar from the University of Cambridge Department of Materials Science and Metallurgy, have won a grant worth over 1.3 million Euros to develop a novel hydrometallurgical process.
Cambridge Enterprise and Qkine Ltd deal to drive stem cell and regenerative medicine research
Cambridge Enterprise, the commercialisation arm of the University of Cambridge, and specialist growth factor manufacturer Qkine Ltd have signed a key licensing deal for Activin A production technology.
Cambridge spin-out STORM Therapeutics expands collaboration with Evotec
Evotec AG announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas. The focus will be on a range of newly discovered RNA modulating enzyme targets.
Sphere Fluidics and partners win InnovateUK grant to develop the world’s first desktop genome
Sphere Fluidics Limited and its partners have just won a £1 million grant to develop a novel automated single cell genome engineering platform.
Cambridge Enterprise CEO receives Lifetime Achievement Award
Tony Raven, CEO of Cambridge Enterprise at the University of Cambridge, has been awarded the Lifetime Achievement Award by Global University Venturing (GUV).
Cambridge alumni’s tech firm start-up Improbable raises $500m
Improbable, founded by Cambridge alumni Herman Narula (Girton 2007) and Rob Whitehead (Robinson 2009), just became the UK's latest $1billion tech start-up.
Z Factor announces £7 million Series A funding to bring lung treatment to clinic
Z Factor Limited announced that it has completed a £7 million Series A investment led by existing investor Medicxi. Cambridge Enterprise & Cambridge Innovation Capital have also joined in the founding round.
Tackling the demand side of the tech transfer equation
Last week, the House of Commons Science and Technology Committee, released findings from its inquiry ‘Managing intellectual property and technology transfer’.
Cambridge Enterprise joins in £14m funding round for spin-out ApcinteX Limited
Cambridge Enterprise has joined in a £14 million Series A funding round into ApcinteX Limited, a University of Cambridge spin-out company developing a new therapy for haemophilia.
University spin-out Cambridge Graphene acquired by Versarien
A majority stake in Cambridge Graphene Ltd., a spin-out company from the University of Cambridge, has been acquired by Versarien plc.
Ventilation technology spin-out Breathing Buildings acquired by Volution Group Plc
Volution Group plc, a leading supplier of ventilation products to the residential and commercial construction markets, has announced that, in line with its strategy, it has acquired the entire share capital of Breathing Buildings Limited. The deal provides an exit for the company’s previous backers including MMC Ventures.
Cambridge Enterprise licenses PARP inhibitor drug IP to Cycle Pharmaceuticals
Cambridge Enterprise has exclusively licensed intellectual property relating to the use of PARP inhibitor drugs for treating vascular disease to Cycle Pharmaceuticals.
Cambridge Enterprise licenses IP to produce platelets from stem cells
Cambridge Enterprise is pleased to announce that it has licensed intellectual property to Platelet BioGenesis, an American biotech start-up developing a method for producing platelets, obviating the need for human blood donation.
Frontier IP acquires 20% stake in University of Cambridge spin-out Tarsis Technology
Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has received a 20% stake in Tarsis Technology Limited (Tarsis), the Group’s third spin-out from the Department of Chemical Engineering and Biotechnology at the University of Cambridge.
8power wins Cambridge Wireless Discovering Startups 2016
8power Limited, a University of Cambridge start up developing smart sensors for industrial applications, has won the 7th CW Discovering Startups Competition.
PervasID secures £720k investment
Cambridge Enterprise, the University of Cambridge Enterprise Fund IV, managed by Parkwalk, and Cambridge Innovation Capital have, together with a private investor, invested £720k in PervasID, a spin-out from the University of Cambridge Engineering Department.
Cambridge Enterprise licenses Tau protein targeting IP to Cantabio Pharmaceuticals
Cambridge Enterprise has announced the completion of a licensing agreement with Cantabio Pharmaceuticals, Inc. that gives the company access to intellectual property from research targeting the Tau protein for the treatment of “Tauopathies” such as Alzheimer’s disease (AD) and dementia.
Young academic minds for hire
Cambridge postdocs are the best in their fields: young academic researchers with the potential to have world-changing impact. But all too often the walls of academia hinder dialogue between industry and researchers. When this happens, that world-changing potential goes unrealised. Cambridge Minds was created to fix that.
Healthera secures investment from Cambridge Enterprise
Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are undisclosed.